主办：上海医药工业研究院
　　　中国药学会
ISSN 1672-9188   CN 31-1939/R   SLYHAA
World Clinical Drug
The lipid-lowering effect of sacubitril valsartan combined with rosuvastatin on patients with acute coronary syndrome after PCI and its impact on the cardiovascular outcomes
NIU Xueyan, a, HUANG Zhimingb, CHEN Feia, SONG Haoming
World Clinical Drug . 2026, (4): 385 .  DOI: 10.13683/j.wph.2026.04.006